Guidance

Coronavirus (COVID-19): evaluation of submissions of diagnostic products

How the Department of Health and Social Care evaluates the submissions of commercially available COVID-19 diagnostic products.

From:
Department of Health and Social Care
Published
20 March 2020
Last updated
14 April 2020 — See all updates

This publication was withdrawn on

This page has been withdrawn because it’s no longer current. Read more about living safely with coronavirus (COVID-19).

Documents

[Withdrawn] Guidance for industry on evaluations of diagnostic products for coronavirus (COVID-19)

HTML

Details

This document provides guidance on how the Department of Health and Social Care evaluates approaches from industry to encourage diagnostic and other scientific innovation.

Updates to this page

Published 20 March 2020
Last updated 14 April 2020 + show all updates

  1. Added following bullet point under list of criteria on which a decision to progress to stage 2 of the rapid evaluation process is based: 'whether the product does or does not conform to any relevant published guidance'.

  2. Updated contact information

  3. Updated email address.

  4. First published.

Sign up for emails or print this page

Related content